These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

250 related articles for article (PubMed ID: 2990652)

  • 21. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. Contribution of antibody-producing B cells, of Epstein-Barr virus-infected B cells, and of immunoglobulin production induced by human T cell lymphotropic virus, type III/lymphadenopathy-associated virus.
    Yarchoan R; Redfield RR; Broder S
    J Clin Invest; 1986 Aug; 78(2):439-47. PubMed ID: 3016028
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Persistent infection with human T-lymphotropic virus type III/lymphadenopathy-associated virus in apparently healthy homosexual men.
    Jaffe HW; Feorino PM; Darrow WW; O'Malley PM; Getchell JP; Warfield DT; Jones BM; Echenberg DF; Francis DP; Curran JW
    Ann Intern Med; 1985 May; 102(5):627-8. PubMed ID: 2984973
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Time relationship of immune changes to HTLV-III/LAV seroconversion in patients with hemophilia.
    Knutsen AP; Bouhasin JD; Lawrence DN; Roodman ST; Mueller KR; McDougal JS; Joist JH
    Ann Allergy; 1986 Nov; 57(5):376-84. PubMed ID: 2946253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A classification of HTLV-III infection based on 75 cases seen in a suburban community.
    Kaplan MH; Pahwa SG; Popovic M; Sarngadharan MG; Gallo RC
    Cancer Res; 1985 Sep; 45(9 Suppl):4655s-4658s. PubMed ID: 2990703
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HTLV and immunosuppression.
    Essex M; Kanki P; Allan J; Barin F; McLane MF; Lee TH; Kitchen L; Homma T; Malone G; Yokota T
    Princess Takamatsu Symp; 1984; 15():309-18. PubMed ID: 6100649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of antibodies against HTLV-III in various regions in Switzerland].
    Schüpbach J; Vogt M; Bhushan R; Lüthy R; Haller O; Joller H; Ferber T; Büchner S; Schuppli R; Schädelin J
    Schweiz Med Wochenschr; 1985 Jul; 115(30):1048-54. PubMed ID: 2994208
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Walter Reed staging classification for HTLV-III/LAV infection.
    Redfield RR; Wright DC; Tramont EC
    N Engl J Med; 1986 Jan; 314(2):131-2. PubMed ID: 2934633
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Acquired immune deficiency syndrome (AIDS)].
    Drusin LM; Stingl G
    Z Hautkr; 1985 Sep; 60(18):1432-60. PubMed ID: 2998109
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A model for the selective loss of major histocompatibility complex self-restricted T cell immune responses during the development of acquired immune deficiency syndrome (AIDS).
    Shearer GM; Bernstein DC; Tung KS; Via CS; Redfield R; Salahuddin SZ; Gallo RC
    J Immunol; 1986 Oct; 137(8):2514-21. PubMed ID: 3489767
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sera from HTLV-III/LAV antibody-positive individuals mediate antibody-dependent cellular cytotoxicity against HTLV-III/LAV-infected T cells.
    Rook AH; Lane HC; Folks T; McCoy S; Alter H; Fauci AS
    J Immunol; 1987 Feb; 138(4):1064-7. PubMed ID: 3027168
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Activation of the macrophage/lymphocyte system in AIDS, ARC and AIDS risk groups].
    Wachter H; Blecha HG; Fuchs D; Hausen A; Hengster P; Hinterhuber H; Reibnegger G; Reissigl H; Rössler H; Schönitzer D
    Wien Klin Wochenschr; 1986 Jul; 98(14):449-54. PubMed ID: 3019018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of long-term seropositivity to human immunodeficiency virus in a cohort of homosexual men.
    Schechter MT; Boyko WJ; Craib KJ; McLeod A; Willoughby B; Douglas B; Constance P; O'Shaughnessey M
    AIDS; 1987 Jul; 1(2):77-82. PubMed ID: 2966631
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diversity of clinical spectrum of HTLV-III infection.
    Valle SL; Saxinger C; Ranki A; Antonen J; Suni J; Lähdevirta J; Krohn K
    Lancet; 1985 Feb; 1(8424):301-4. PubMed ID: 2857362
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Exposure to human T-lymphotropic virus type III/lymphadenopathy-associated virus and immunologic abnormalities in asymptomatic homosexual men.
    Nicholson JK; McDougal JS; Jaffe HW; Spira TJ; Kennedy MS; Jones BM; Darrow WW; Morgan M; Hubbard M
    Ann Intern Med; 1985 Jul; 103(1):37-42. PubMed ID: 2988389
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Vancouver Lymphadenopathy-AIDS Study: 6. HIV seroconversion in a cohort of homosexual men.
    Schechter MT; Boyko WJ; Douglas B; Willoughby B; McLeod A; Maynard M; Craib KJ; O'Shaughnessy M
    CMAJ; 1986 Dec; 135(12):1355-60. PubMed ID: 3022904
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Factors affecting seropositivity to human T cell lymphotropic virus type III (HTLV-III) or lymphadenopathy associated virus (LAV) and progression of disease in sexual partners of patients with AIDS.
    Weber JN; McCreaner A; Berrie E; Wadsworth J; Jeffries DJ; Pinching AJ; Harris JR
    Genitourin Med; 1986 Jun; 62(3):177-80. PubMed ID: 3015772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. HTLV-III: the etiologic agent of AIDS.
    Sarngadharan MG; DeVico AL; Bruch L; Schüpbach J; Gallo RC
    Princess Takamatsu Symp; 1984; 15():301-8. PubMed ID: 6100648
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human T cell leukemia virus type III antibody, lymphadenopathy, and acquired immune deficiency syndrome in hemophiliac subjects. Results of a prospective study.
    Kreiss JK; Kitchen LW; Prince HE; Kasper CK; Goldstein AL; Naylor PH; Preble O; Stewart JA; Essex M
    Am J Med; 1986 Mar; 80(3):345-50. PubMed ID: 3006485
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human T-lymphotropic retrovirus type III (HTLV-III) in Danish homosexuals.
    Lange Wantzin G; Saxinger WC; Weismann K; Gallo RC
    Acta Derm Venereol; 1985; 65(3):247-50. PubMed ID: 2411083
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of antibodies to AIDS-associated retrovirus in in- and out-patients in Japan.
    Ikegami N
    AIDS Res; 1986 Dec; 2 Suppl 1():S29-34. PubMed ID: 3103640
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.